Resistance to Proteasome Inhibitors in Cancer

癌症的蛋白酶体抑制剂阻抗:克服阻抗的分子机制与策略

肿瘤学

原   价:
1657.5
售   价:
1326.00
优惠
平台大促 低至8折优惠
作      者
出版时间
2014年09月15日
装      帧
精装
ISBN
9783319067513
复制
页      码
390
语      种
英语
综合评分
暂无评分
我 要 买
- +
库存 30 本
  • 图书详情
  • 目次
  • 买家须知
  • 书评(0)
  • 权威书评(0)
图书简介
The book explores cutting-edge strategies to overcome proteasome inhibitor resistance, including the second generation 20S proteasome inhibitors, novel combinational therapies, and new targets in the ubiquitin-proteasome pathway (e.g., ubiquitin E3 ligases, deubiquitinases, 19S proteasomal ATPases, histone deacetylases, oxidative stress and proteotoxic stress pathways and pharmacogenomic signature profiling) in resistant cancer cells. The mechanisms of action and resistance of proteasome inhibitors, such as bortezomib and carfilzomib in human cancers, including multiple myeloma, mantle cell lymphoma, acute leukemia, and solid tumors are explored in depth in this volume.This timely volume unveils the most current discoveries of the mechanisms behind proteasome inhibitor resistance, which will help illuminate the future of cancer therapies.
本书暂无推荐
本书暂无推荐
看了又看
  • 上一个
  • 下一个